EquityBulls

Latest News

Keywords Selected: USFDA

Stock Report

Granules India Ltd received ANDA Approval for Losartan and Hydrochlorothiazide Tablets
Aurobindo Pharma Ltd gets Form 483 from USFDA with 1 observation
Lupin Receives EIR from U.S. FDA for its Nagpur Unit-1 Manufacturing Facility
USFDA inspection at Piramal Pharma Ltd's Bethlehem facility
USFDA Delegation visits Divi's Laboratories Limited's Unit I at Choutuppal, Telangana, India
Gland Pharma Ltd receives EIR from USFDA for Pashamylaram Facility at Hyderabad
Sequent Scientific Ltd gets Form 483 with One Observation from USFDA for Vizag facility
Strides receives USFDA approval for Icosapent Ethyl Capsules
USFDA inspection at InvaGen manufacturing facility in Central Islip, Long Island, NY, USA
Zydus receives final approval from the USFDA for Clindamycin Phosphate Gel USP, 1%
Caplin Steriles gets USFDA approval for Norepinephrine Bitartrate Injection
Completion of US FDA Inspection at Unit IV of APL Healthcare Ltd
Zydus receives EIR for the formulation manufacturing facility at SEZ 2, Ahmedabad
Strides receives tentative USFDA approval for Dolutegravir / Lamivudine / Tenofovir Disproxil Fumurate tablets
Zydus receives final approval from the USFDA for Norelgestromin and Ethinyl Estradiol Transdermal System, 150 mcg/35 mcg per day
Strides receives tentative USFDA approval for Dolutegravir tablets
Bajaj Healthcare Ltd receives EIR from USFDA for API manufacturing facility in Savli
Zydus receives EIR for the injectables manufacturing facility at Zydus Biotech Park, Ahmedabad
Strides receives USFDA approval for Sevelamer Carbonate for Oral Suspension
Aurobindo Pharma Ltd updates on US FDA inspection at Unit 3
Caplin Steriles receives EIR from US FDA
Zydus receives final approval from the USFDA for Erythromycin Tablets USP, 250 mg and 500 mg
Zydus receives final approval from the USFDA for Isotretinoin Capsules USP, 10 mg, 20 mg 30 mg and 40 mg
Ajanta Pharma Ltd receives final approval from US FDA for Topiramate Extended Release Capsules